IDEAYA Biosciences, Inc. (IDYA)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-04) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-05) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-17) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-04) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-05) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-06) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-13) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-04) · 99.1 | ||
| 10-Q/A | Q1-2024 | |||
| 10-Q | Q2-2024 | 8-K (2024-08-06) · 99.1 | 8-K (2024-07-09) | ||
| 10-Q | Q1-2024 | 8-K (2024-05-07) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-20) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-07) · 99.1 | 8-K (2023-10-24) |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Condensed Statements of Operations and Comprehensive Income (loss) | — |
|
| Statements of Operations and Comprehensive Loss | ||
| Statements of Stockholders' Equity | ||
| Statements of Cash Flows | ||
| Notes | ||
| Balance Sheet Components | ||
| Commitments and Contingencies | ||
| Common Stock | ||
| Cybersecurity Risk Management, Strategy, and Governance | — |
|
| Fair Value Measurement and Marketable Securities | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Net Income (loss) Per Share Attributable To Common Stockholders | — |
|
| Net Loss Per Share Attributable To Common Stockholders | ||
| Operating Leases | ||
| Organization | ||
| Pay Vs Performance Disclosure | ||
| Revenue Recognition | ||
| Segment Information | ||
| Significant Agreements | ||
| Stock-based Compensation | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||